Literature DB >> 23461754

Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma.

Eiji Tamoto1, Satoshi Hirano, Takahiro Tsuchikawa, Eiichi Tanaka, Masaki Miyamoto, Joe Matsumoto, Kentaro Kato, Toshiaki Shichinohe.   

Abstract

OBJECTIVES: To assess the safety and feasibility and discuss the oncological impact of a portal vein resection using the no-touch technique with a hepatectomy for locally advanced hilar cholangiocarcinoma. PATIENTS AND METHODS: From 2005 to March 2009, 49 patients with hilar cholangiocarcinoma underwent a major right-sided hepatectomy with curative intent. Portal vein resection was performed using the no-touch technique in 36 patients (PVR group) but the portal vein was not resected in the other 13 patients (NR group). Peri-operative data and histological findings were compared between the two groups. Moreover, tumour recurrence and survival rates after surgery were calculated and compared for each group.
RESULTS: Although the tumours of the patients in the PVR group were more locally advanced, the residual tumour status and tumour recurrence rate were similar and there was no significant difference in long-term survival between the two groups: 5-year survival rates in the PVR and NR groups were 59% and 51%, respectively (P = 0.353). In-hospital mortality was encountered in 2 of the 49 patients.
CONCLUSION: A portal vein resection using the no-touch technique with a right-sided hepatectomy had a positive impact on survival and is feasible in terms of long-term outcomes with acceptable mortality.
© 2013 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2013        PMID: 23461754      PMCID: PMC3892315          DOI: 10.1111/hpb.12067

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  13 in total

1.  Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection.

Authors:  Luis Muñoz; Sasan Roayaie; Daniel Maman; Thomas Fishbein; Patricia Sheiner; Sukru Emre; Charles Miller; Myron E Schwartz
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

2.  Surgical management of hilar cholangiocarcinoma: the Nagoya experience.

Authors:  Hideki Nishio; Masato Nagino; Yuji Nimura
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

3.  Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?

Authors:  Masaru Miyazaki; Atsushi Kato; Hiroshi Ito; Fumio Kimura; Hiroaki Shimizu; Masayuki Ohtsuka; Hiroyuki Yoshidome; Hideyuki Yoshitomi; Katsunori Furukawa; Satoshi Nozawa
Journal:  Surgery       Date:  2007-03-23       Impact factor: 3.982

4.  Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma.

Authors:  A Kobayashi; S Miwa; T Nakata; S Miyagawa
Journal:  Br J Surg       Date:  2010-01       Impact factor: 6.939

5.  Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality.

Authors:  Satoshi Hirano; Satoshi Kondo; Eiichi Tanaka; Toshiaki Shichinohe; Takahiro Tsuchikawa; Kentaro Kato; Joe Matsumoto; Ryosuke Kawasaki
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-08       Impact factor: 7.027

6.  Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.

Authors:  Peter Neuhaus; Armin Thelen; Sven Jonas; Gero Puhl; Timm Denecke; Wilfried Veltzke-Schlieker; Daniel Seehofer
Journal:  Ann Surg Oncol       Date:  2011-10-01       Impact factor: 5.344

7.  Does portal vein resection with hepatectomy improve survival in locally advanced hilar cholangiocarcinoma?

Authors:  Gi-Won Song; Sung-Gyu Lee; Shin Hwang; Ki-Hun Kim; Yong-Pil Cho; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha
Journal:  Hepatogastroenterology       Date:  2009 Jul-Aug

8.  No-touch resection of hilar malignancies with right hepatectomy and routine portal reconstruction.

Authors:  Satoshi Hirano; Satoshi Kondo; Eiichi Tanaka; Toshiaki Shichinohe; Takahiro Tsuchikawa; Kentaro Kato
Journal:  J Hepatobiliary Pancreat Surg       Date:  2009-04-10

9.  Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

Authors:  William R Jarnagin; Leyo Ruo; Sarah A Little; David Klimstra; Michael D'Angelica; Ronald P DeMatteo; Raquel Wagman; Leslie H Blumgart; Yuman Fong
Journal:  Cancer       Date:  2003-10-15       Impact factor: 6.860

10.  Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study.

Authors:  Satoshi Kondo; Satoshi Hirano; Yoshiyasu Ambo; Eiichi Tanaka; Shunichi Okushiba; Toshiaki Morikawa; Hiroyuki Katoh
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

View more
  18 in total

1.  Bile duct surgery in the treatment of hepatobiliary and gallbladder malignancies: effects of hepatic and vascular resection on outcomes.

Authors:  Perry Shen; Nora Fino; Edward A Levine; Pamela Eversole; Clancy Clark
Journal:  HPB (Oxford)       Date:  2015-09-16       Impact factor: 3.647

2.  Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma.

Authors:  Ryusei Matsuyama; Daisuke Morioka; Ryutaro Mori; Yasuhiro Yabushita; Seigo Hiratani; Yohei Ota; Takafumi Kumamoto; Itaru Endo
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

Review 3.  The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

Authors:  Neil Bhardwaj; Giuseppe Garcea; Ashley R Dennison; Guy J Maddern
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

Review 4.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

Review 5.  Surgical resection techniques for locally advanced hilar cholangiocarcinoma.

Authors:  Sanjay Govil; Mettu Srinivas Reddy; Mohamed Rela
Journal:  Langenbecks Arch Surg       Date:  2014-06-04       Impact factor: 3.445

6.  Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium.

Authors:  Gregory V Schimizzi; Linda X Jin; Jesse T Davidson; Bradley A Krasnick; Cecilia G Ethun; Timothy M Pawlik; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Sharon M Weber; Ahmed Salem; William G Hawkins; Steven M Strasberg; Maria B Doyle; William C Chapman; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Ryan C Fields
Journal:  HPB (Oxford)       Date:  2017-11-21       Impact factor: 3.647

7.  Total Hilar En Bloc Resection with Left Hemihepatectomy and Caudate Lobectomy: a Novel Approach for Treatment of Left-Sided Perihilar Cholangiocarcinoma (with Video).

Authors:  Cai De Lu; Jing Huang; Sheng Dong Wu; Yong Fei Hua; Ammar A Javed; Jiong Zhe Fang; Chun Nian Wang; Sheng Ye
Journal:  J Gastrointest Surg       Date:  2017-09-05       Impact factor: 3.452

8.  Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resection.

Authors:  Víctor Molina; Jaime Sampson; Joana Ferrer; Alba Díaz; Juan Ramon Ayuso; Santiago Sánchez-Cabús; Josep Fuster; Juan Carlos García-Valdecasas
Journal:  Langenbecks Arch Surg       Date:  2016-12-23       Impact factor: 3.445

9.  Combined portal vein resection for hilar cholangiocarcinoma.

Authors:  Tao Bai; Jie Chen; Zhi-Bo Xie; Liang Ma; Jun-Jie Liu; Shao-Liang Zhu; Fei-Xiang Wu; Le-Qun Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 10.  Resection for Klatskin tumors: technical complexities and results.

Authors:  Ivan Capobianco; Jens Rolinger; Silvio Nadalin
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.